Williams et al., 2013 - Google Patents
Towards standardizing methodology for quantifying the fine particle mass (dose) of active pharmaceutical ingredient (API) from nasal products (NPs) on behalf of the …Williams et al., 2013
View PDF- Document ID
- 9288508867930809022
- Author
- Williams G
- Bickmann D
- Schiewe J
- Hauviller C
- Blatchford C
- Doub W
- Mitchell J
- Nichols S
- Suman J
- Weda M
- Publication year
External Links
Snippet
Pharmacopeial methods for the assessment of inhaled nasal products (NPs), including nasal pressurized metereddose inhalers and aqueous spray pumps, lack clearly defined methodology for determining the mass of fine particles that may penetrate beyond the …
- 238000000034 method 0 title abstract description 16
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/003—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
- A61M2016/0033—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mitchell et al. | Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations | |
| Zhang et al. | Particle deposition measurements and numerical simulation in a highly idealized mouth–throat | |
| Chen et al. | In vitro assessment of an idealized nose for nasal spray testing: Comparison with regional deposition in realistic nasal replicas | |
| Kaviratna et al. | Evaluation of bio-relevant mouth-throat models for characterization of metered dose inhalers | |
| EP3959707B1 (en) | Methods and systems for simulating deposition of inhaled drug on lungs | |
| Clark et al. | In vitro testing of pharmaceutical aerosols and predicting lung deposition from in vitro measurements | |
| Oliveira et al. | pMDI sprays: Theory, experiment and numerical simulation | |
| Tavernini et al. | Scaling an idealized infant nasal airway geometry to mimic inertial filtration of neonatal nasal airways | |
| Kugler et al. | Determination of emitted particle characteristics and upper airway deposition of Symbicort® Turbuhaler® dry powder inhaler | |
| Martonen et al. | Use of analytically defined estimates of aerosol respirable fraction to predict lung deposition patterns | |
| Wachtel et al. | In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1–5-year-old children with persistent asthmatic symptoms | |
| Lewis et al. | Exploring the impact of sample flowrate on in vitro measurements of metered dose inhaler performance | |
| Zhou et al. | Numerical study on the effect of the realistic mouth-inhaler positions on orally inhaled drug delivery in pediatric intersubject upper airways | |
| Biddiscombe et al. | A system for the production and delivery of monodisperse salbutamol aerosols to the lungs | |
| Williams et al. | Evaluation of nasal inlet ports having simplified geometry for the pharmacopeial assessment of mass fraction of dose likely to penetrate beyond the nasopharynx: a preliminary investigation | |
| Williams et al. | Towards standardizing methodology for quantifying the fine particle mass (dose) of active pharmaceutical ingredient (API) from nasal products (NPs) on behalf of the European Pharmaceutical Aerosol Group (EPAG) in DDL (Drug Delivery to the Lungs) 24 | |
| Sonnenberg et al. | Breath hold facilitates targeted deposition of aerosolized droplets in a 3D printed bifurcating airway tree | |
| Kesten et al. | Development of a novel digital breath-activated inhaler: Initial particle size characterization and clinical testing | |
| Doub et al. | Laboratory performance testing of aqueous nasal inhalation products for droplet/particle size distribution: An assessment from the international pharmaceutical aerosol consortium on regulation and science (IPAC-RS) | |
| Jahed et al. | Mucus, airway and plume temperature effects on pMDI-drug delivery in a mouth-throat airway: Experimental and numerical studies | |
| Finlay et al. | Validating deposition models in disease: what is needed? | |
| Finlay | Aerosol physics and lung deposition modeling | |
| Copley et al. | Improving the realism and relevance of mouth-throat models for inhaled product testing | |
| Mitchell | Aerodynamic Particle Size Testing | |
| Copley et al. | Using breathing simulators to enhance inhaled product testing |